• LAST PRICE
    21.6900
  • TODAY'S CHANGE (%)
    Trending Down-0.4900 (-2.2092%)
  • Bid / Lots
    21.6800/ 1
  • Ask / Lots
    21.7300/ 3
  • Open / Previous Close
    22.3300 / 22.1800
  • Day Range
    Low 21.2600
    High 22.4200
  • 52 Week Range
    Low 11.8300
    High 28.8000
  • Volume
    85,965
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 22.18
TimeVolumeRGNX
09:32 ET680222.34
09:34 ET60022.12
09:36 ET81921.82
09:39 ET40021.81
09:45 ET58221.885
09:48 ET526421.755
09:50 ET31721.66
09:52 ET178721.485
09:54 ET37021.46
09:57 ET47021.555
09:59 ET20021.45
10:01 ET140021.425
10:03 ET20021.32
10:06 ET20021.34
10:08 ET381221.27
10:10 ET10021.26
10:12 ET92621.27
10:14 ET60021.27
10:15 ET120021.45
10:17 ET10021.45
10:19 ET10021.43
10:24 ET192221.52
10:26 ET30021.375
10:28 ET47121.442
10:30 ET50021.38
10:32 ET20021.36
10:33 ET40021.38
10:35 ET159521.55
10:37 ET10021.545
10:39 ET60021.6
10:42 ET50021.63
10:44 ET103921.755
10:46 ET10021.81
10:48 ET137521.695
10:50 ET20021.76
10:51 ET20021.77
10:53 ET80721.77
10:55 ET10021.82
11:00 ET269421.74
11:02 ET31321.7
11:06 ET10021.67
11:08 ET10021.66
11:09 ET20021.72
11:11 ET30021.685
11:15 ET198921.61
11:18 ET77621.65
11:20 ET10021.62
11:24 ET20021.65
11:26 ET80021.67
11:29 ET30021.67
11:31 ET60021.7
11:36 ET40021.66
11:38 ET43921.66
11:40 ET60021.68
11:42 ET10021.6947
11:44 ET14721.694
11:47 ET60021.685
11:49 ET109921.63
11:51 ET100721.63
11:54 ET60021.69
11:56 ET10021.68
11:58 ET30821.68
12:00 ET30021.66
12:02 ET10021.68
12:05 ET96021.66
12:09 ET10021.61
12:14 ET50021.645
12:16 ET53321.61
12:18 ET10021.635
12:20 ET40021.66
12:21 ET10021.63
12:23 ET10021.68
12:25 ET40021.71
12:27 ET10021.7
12:30 ET10021.74
12:32 ET30021.69
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRGNX
Regenxbio Inc
1.1B
-3.6x
---
United StatesSAGE
SAGE Therapeutics Inc
1.1B
-2.1x
---
United StatesARQT
Arcutis Biotherapeutics Inc
1.1B
-2.5x
---
United StatesPRTA
Prothena Corporation PLC
1.4B
-8.8x
---
United StatesVIR
Vir Biotechnology Inc
1.4B
-2.2x
---
United StatesIMTX
Immatics NV
1.1B
-8.5x
---
As of 2024-03-28

Company Information

REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.

Contact Information

Headquarters
9804 Medical Center DriveROCKVILLE, MD, United States 20850
Phone
240-552-8181
Fax
302-655-5049

Executives

Chairman of the Board
Allan Fox
President, Chief Executive Officer, Director
Kenneth Mills
Chief Financial Officer, Executive Vice President
Vittal Vasista
Chief Operating Officer, Executive Vice President
Curran Simpson
Executive Vice President, Chief Scientific Officer
Olivier Danos

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1B
Revenue (TTM)
$90.2M
Shares Outstanding
48.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.28
EPS
$-6.03
Book Value
$7.08
P/E Ratio
-3.6x
Price/Sales (TTM)
11.9
Price/Cash Flow (TTM)
---
Operating Margin
-297.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.